Bill > HB2127

This bill, named "Cindi's Law", introduces new provisions for uterine cancer testing by requiring that all abnormal endometrial samples undergo a p53 test. The bill defines key terms: an "endometrial sample" is tissue collected from the uterine lining for diagnostic purposes, and a "p53 test" is a diagnostic test that examines the p53 protein in tissue samples to assess cancer's invasiveness, severity, and potential prognosis. Specifically, the legislation mandates that when a medical professional identifies an abnormal cytological or histological endometrial sample, they must perform a p53 test in addition to any other standard diagnostic tests. This requirement aims to enhance the accuracy and comprehensiveness of uterine cancer diagnosis by providing additional insights into the potential characteristics and risks of abnormal tissue samples.

https://house.mo.gov/Bill.aspx?bill=HB2127&year=2026&code=R